TickerFacts.

Biodesix Inc (BDSX): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$2.46M
As of 2025-12-31
$9.14M
As of 2026-06-30
$41.17M2019-12-31: -$225.14M2020-12-31: $41.17M2021-12-31: $19.73M2022-12-31: $20.61M2023-12-31: $4.58M2024-12-31: $20.88M2025-12-31: -$2.46M-$2.46M
2019-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$2.46Mn/m2026-02-26, Balance as of period end
2024-12-31$20.88M+355.8%2026-02-26, Balance as of period end
2023-12-31$4.58M-77.8%2025-03-03, Balance as of period end
2022-12-31$20.61M+4.5%2024-03-01, Balance as of period end
2021-12-31$19.73M-52.1%2023-03-06, Balance as of period end
2020-12-31$41.17Mn/m2023-03-06, Balance as of period end
2019-12-31-$225.14Mn/a2021-03-16, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Biodesix Inc (BDSX)2025-12-31-$2.46Mn/m
Personalis, Inc. (PSNL)2025-12-31$261.19M+28.7%
Exagen Inc. (XGN)2025-12-31$17.45M+82.9%
GRAIL, Inc. (GRAL)2025-12-31$2.58B+3.0%
American Shared Hospital Services (AMS)2025-12-31$27.69M-7.8%
BillionToOne, Inc. (BLLN)2025-12-31$480.11Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31$1.11B-1.9%
Castle Biosciences Inc (CSTL)2025-12-31$470.87M+3.3%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%

Compare BDSX, PSNL, XGN, GRAL side by side · Screen every company in Services-Medical Laboratories ↗